Abstract
The purpose of this study was to quantify the antibiotics prescribed in the outpatient setting of all primary health care professionals in Catalonia during 1992–2007. We calculated prescribed defined daily doses per 1,000 inhabitants and day (DID) from data provided by the Catalonian Health Service. The antibiotics analysed belonged to the J01 group (ATC/DDD classification). The overall prescribing of antibacterials has decreased by 11.9% during this period (1992: 16.75 DID, 2007: 14.75 DID). During this 16-year period, an increase was observed for penicillins (from 46.1% in 1992 to 59.6% in 2007) and for quinolones (from 13.3% to 15.7%). The prescription of cephalosporins remained steady and, conversely, a decrease in macrolides was found (from 14.8% to 12.2%). The leading antibiotic prescribed in 2007 was amoxicillin plus clavulanic acid (5.15 DID), followed by amoxicillin (2.95 DID). The former has increased by 84.4% since 2002. Penicillin V prescribing reached a peak in 2007 with 0.034 DID. There has been a slight reduction in antibiotic prescription in this 16-year study, with an increase of penicillins, mainly at the expense of those of broader antibacterial spectrum. Awareness of the rational use of antibiotics is mandatory, basically aimed at reducing the overall prescribing of antibiotics and encouraging those with a narrower spectrum.
Similar content being viewed by others
References
Cars O, Mölstad S, Melander A (2001) Variation in antibiotic use in the European Union. Lancet 357:1851–1853. doi:10.1016/S0140-6736(00)04972-2
Goossens H, Ferech M, Coenen S et al; European Surveillance of Antimicrobial Consumption Project Group (2007) Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. Clin Infect Dis 44:1091–1095. doi:10.1086/512810
Ferech M, Coenen S, Malhotra-Kumar S et al; ESAC Project Group (2006) European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. J Antimicrob Chemother 58:401–407. doi:10.1093/jac/dkl188
Departament de Salut. Generalitat de Catalunya. Campanya de sensibilització sobre l’ús correcte dels antibiòtics. Available online at: doi:http://www.gencat.cat/salut/depsalut/html/ca/dir1983/antdex.htm
Goossens H, Ferech M, Vander Stichele R et al; ESAC Project Group (2005) Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365:579–587
Bronzwaer SL, Cars O, Buchholz U et al; European Antimicrobial Resistance Surveillance System (2002) A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 8:278–282
Peleg AY, Paterson DL (2006) Modifying antibiotic prescribing in primary care. Clin Infect Dis 42:1231–1233. doi:10.1086/503042
Arroll B (2005) Antibiotics for upper respiratory tract infections: an overview of Cochrane reviews. Respir Med 99:255–261. doi:10.1016/j.rmed.2004.11.004
Smucny J, Fahey T, Becker L et al (2004) Antibiotics for acute bronchitis. Cochrane Database Syst Rev 4:CD000245
Mölstad S, Erntell M, Hanberger H et al (2008) Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect Dis 8:125–132. doi:10.1016/S1473-3099(08)70017-3
Little PS, Gould C, Williamson I et al (1997) Reattendance and complications in a randomised trial of prescribing strategies for sore throat: the medicalising effect of prescribing antibiotics. BMJ 315:350–352
Livermore DM (2005) Minimising antibiotic resistance. Lancet Infect Dis 5:450–459. doi:10.1016/S1473-3099(05)70166-3
Cars O, Högberg LD, Murray M et al (2008) Meeting the challenge of antibiotic resistance. BMJ 337:a1438. doi:10.1136/bmj.a1438
Carrie AG, Zhanel GG (1999) Antibacterial use in community practice: assessing quantity, indications and appropriateness, and relationship to the development of antibacterial resistance. Drugs 57:871–881. doi:10.2165/00003495-199957060-00004
World Health Organization Collaborating Centre for Drug Statistics Methodology (2006) Anatomical Therapeutic Chemical (ATC) classification index with Defined Daily Doses (DDDs). WHO Collaborating Centre for Drug Statistics Methodology, Oslo, Norway. Home page at: doi:http://www.whocc.no/atcddd/
Capellà D (1993) Descriptive tools and analysis. WHO Reg Publ Eur Ser 45:55–78
Monnet DL, Mölstad S, Cars O (2004) Defined daily doses of antimicrobials reflect antimicrobial prescriptions in ambulatory care. J Antimicrob Chemother 53:1109–1111. doi:10.1093/jac/dkh230
Lázaro E, Madurga M, de Abajo FJ (2002) Evolución del consumo de antibióticos en España, 1985–2000. Med Clin (Barc) 118:561–568
Campos J, Ferech M, Lázaro E et al (2007) Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data. J Antimicrob Chemother 60:698–701. doi:10.1093/jac/dkm248
Bremón AR, Ruiz-Tovar M, Pérez Gorricho B et al (2000) Non-hospital consumption of antibiotics in Spain: 1987–1997. J Antimicrob Chemother 45:395–400. doi:10.1093/jac/45.3.395
Ripoll Lozano MA, Jiménez Arce JI, Pedraza Dueñas A (2007) Variabilidad en la prescripción de antibióticos en la provincia de Ávila. Rev Esp Quimioter 20:44–50
Roumie CL, Halasa NB, Grijalva CG et al (2005) Trends in antibiotic prescribing for adults in the United States—1995 to 2002. J Gen Intern Med 20:697–702. doi:10.1111/j.1525-1497.2005.0148.x
Andrade RJ, Lucena MI, Fernández MC et al (2005) Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 129:512–521
Sabaté M, Ibáñez L, Pérez E et al (2007) Risk of acute liver injury associated with the use of drugs: a multicentre population survey. Aliment Pharmacol Ther 25:1401–1409
Ferech M, Coenen S, Dvorakova K et al; ESAC Project Group (2006) European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe. J Antimicrob Chemother 58:408–412. doi:10.1093/jac/dkl186
Elseviers MM, Ferech M, Vander Stichele RH et al; ESAC Project Group (2007) Antibiotic use in ambulatory care in Europe (ESAC data 1997–2002): trends, regional differences and seasonal fluctuations. Pharmacoepidemiol Drug Saf 16:115–123. doi:10.1002/pds.1244
Coenen S, Ferech M, Malhotra-Kumar S et al; ESAC Project Group (2006) European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe. J Antimicrob Chemother 58:418–422. doi:10.1093/jac/dkl184
van Duijn HJ, Kuyvenhoven MM, Butler CC et al (2005) Variation in outpatient antibiotic use in three European countries: exploration of possible determinants. Eur J Gen Pract 11:139–140
Steinman MA, Gonzales R, Linder JA et al (2003) Changing use of antibiotics in community-based outpatient practice, 1991–1999. Ann Intern Med 138:525–533
Linder JA, Huang ES, Steinman MA et al (2005) Fluoroquinolone prescribing in the United States: 1995 to 2002. Am J Med 118:259–268. doi:10.1016/j.amjmed.2004.09.015
Rao GG, Patel M (2009) Urinary tract infection in hospitalized elderly patients in the United Kingdom: the importance of making an accurate diagnosis in the post broad-spectrum antibiotic era. J Antimicrob Chemother 63:5–6. doi:10.1093/jac/dkn458
Finch R, Hunter PA (2006) Antibiotic resistance—action to promote new technologies: report of an EU Intergovernmental Conference held in Birmingham, UK, 12–13 December 2005. J Antimicrob Chemother 58(Suppl S1):i3–i22
Worrall G, Hutchinson J, Sherman G et al (2007) Diagnosing streptococcal sore throat in adults: randomized controlled trial of in-office aids. Can Fam Physician 53:667–671
Conflicts of interest
None declared.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Llor, C., Cots, J.M., Gaspar, M.J. et al. Antibiotic prescribing over the last 16 years: fewer antibiotics but the spectrum is broadening. Eur J Clin Microbiol Infect Dis 28, 893–897 (2009). https://doi.org/10.1007/s10096-009-0719-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-009-0719-3